Introduction Nocardial arthritis in immunocompetent patients is rare, and the optimum duration of antimicrobial therapy is unknown, although several months of antibiotic treatment is often recommended. Case report We here report the first case of human infection with a novel Nocardia sp., summarise the epidemiology of nocardial arthritis and outline the feasibility of relatively short antibiotic treatments after careful surgical drainage.
Introduction
Nocardia spp are aerobic Gram-positive bacteria that are considered to be ubiquitous soil saprophytes [1] . The genus encompasses more than 20 species [2] , and new species are continuously being identified [2] . Human infections caused by Nocardia spp often appear as pneumonia [2] or disseminated diseases in severely immunocompromised hosts [1, 3] . Cotrimoxazole remains the antibiotic of choice [1, [3] [4] [5] [6] [7] .
Nocardial arthritis in immunocompetent patients is very rare. Although no studies have compared the drainage procedure to the no-drainage procedure, the vast majority of experts recommend joint drainage in patients with septic arthritis [4] . In contrast, the duration of concomitant antibiotic treatment remains unknown only single case reports have been published.
We report here the first human infection with a novel Nocardia sp. that occurred as a posttraumatic arthritis in an immunocompetent host. We further discuss the feasibility of a relatively short antibiotic treatment after an adequate surgical drainage procedure and review the literature.
Case report
A 40-year-old epileptic patient survived a car accident in the Rhone Valley, France, in May 2, 2008 . He suffered open fractures (grade IIIb) of both ankles that were contaminated by earth, which were initially washed and then stabilised with intramedullar nailing. The patient received empirical antibiotic treatment of amoxicillin/clavulanate for 5 days. After his transfer to the Geneva University Hospitals, an elective surgical revision was necessary because of incongruence of the articular surfaces. On May 15, both intramedullar nails were removed, and the ankles were stabilised with external tibio-tarsal fixation devices (Hoffmann II) with the intention that these devices remain in place for 6 weeks. However, on June 19, the patient developed clinical signs of arthritis on his right ankle (erythema, tenderness, pain) with a purulent discharge of the scar. He had no concomitant fever, and the serum C-reactive protein level was 52 mg/L. All external fixation and thus all foreign material were therefore removed after 5 weeks, 1 week earlier than initially scheduled. The bone was considered to be sufficiently consolidated so that no new fixation was necessary on the infected ankle. The patient was given instructions on how to discharge his leg for another 2 months. Gram-staining and microscopic examination of the pus did not show any pathogen or crystal. The patient was empirically treated with intravenous vancomycin 2 g/day and ceftriaxone 2 g/day. Five days later, colonies of a Nocardia sp. appeared on microbiological cultures of the pus. The antibiotic treatment was changed to intravenous cotrimoxazole (160 mg trimethroprim/800 mg sulfamethoxazol; three times daily) for 5 days, followed by oral cotrimoxazole 960 mg (doublestrength tablets) twice daily for a total of 8 weeks (until August 26). The fourth and last drainage performed on July 4 revealed that the surgical site was sterile. The cure was considered to be complete, and the patient has had no recurrence based on a follow-up at 20 months. No underlying immunosuppression was detected at that time.
Microbiology

Phenotypical diagnosis
The Nocardia were cultured on Columbia agar incubated aerobically at 35°C in an atmosphere enriched with 5% CO 2 [3, 8, 9] . Laboratory examination revealed beaded/ branching, acid-fast, Gram-positive rods that were positive for b-lactamase, glucolysis and urease production. All tests for hydrolysis (casein, xanthine and tyrosine) were negative, as was the reduction of nitrate, growth at 45°C, fermentation of maltose and the test for esculin. The tests for casein hydrolysis involved a culture period of 14 days, those for xanthine, 3 weeks and those for tyrosine, 4 weeks.
Based on these phenotypical characteristics, the cultured Nocardia was classified as being closest to N. beijingensis [8, 9] . Antimicrobial minimal inhibitory concentrations (MICs) were determined by the E test (AB Biodisk, Solna, Sweden). The bacterium was susceptible to imipenem, tobramycin, kanamycin, tetracyclines and cotrimoxazole with corresponding MICs of 0.38, 1.5, 0.12, 0.064 and 0.25 mg/L, respectively.
Gene sequencing
The sequence of the 16S rRNA gene [10] was determined by a capillary sequence analyser (ABI 3130 XL DNA analyser; Applied Biosystems, Foster City, CA). Over a 979-bp fragment (region 49-1,027 of the 16S rRNA gene), our strain (GenBank Accession no. GQ281125) showed three nucleotide differences when compared to N. beijingensis [2] (GenBank Accession no. AF154129) and only one nucleotide difference with strains from Thailand and Japan [8] (DDBJ Accession no. AB094639-AB094656). Different sequences of Nocardia sp. and one sequence of N. asteroides (Accession no. Z82227) were also very close to our strain. Although sequence analysis of the 16S rRNA gene is adequate for the identification of numerous Nocardia sp., it is known that the speciation of some isolates requires the analysis of another gene target. The gene seqA1 has been described as a more discriminative method [11] . With this approach, our clinical isolate had a seqA1 gene showing at least 21 mismatches over 522 bp when compared to strains N. beijingensis, N. arthritidis or N. abscessus. Table 1 summarises other clinical and epidemiological aspects of the 26 published cases of nocardial arthritis we identified in the English literature. In one-third of all cases, nocardial arthritis presented secondary to pneumonia, and in one-fourth it was related to a traumatic origin. The knee joint was involved in half of the cases, and most infections were due to N. asteroides. One-half of the patients were immunocompromised, and male patients predominated. Cotrimoxazole was used in two-thirds of cases, and the average number of surgical interventions per case was 2.3.
Review of the literature
Discussion
We report here the first case of human infection with a novel Nocardia sp. that closely resembles N. beijingensis phenotypically. It clearly came from the soil that penetrated the open fractures of the patient. In a study carried out in 2001, N. beijingensis was detected in the soil around Beijing [2] . In 2004, microbiologists retrospectively identified 19 human cases of N. beijingensis infection in Japan and Thailand [8, 12] . Our phenotypical results are in agreement with the phenotypic characteristics reported in these earlier studies, with the exception of a negative growth test at 45°C, while the Asian study reported positive growth. Phenotypically, N. abscessus is frequently nitratepositive and imipenem-resistant, N. arthritidis is nitrate Reminder: a 1-day oral dose of two double-strength tablets of cotrimoxazole is 1,920 mg positive and grows at 45°C and N. beijingensis is xanthinepositive. Our strain is also genetically close to N. asteroides, N. abscessus and N. beijingensis based on 16S rDNA sequencing [10] , but substantial differences were documented in the seqA1 gene [11] , thus formally excluding N. beijingensis. We found no match for our strain in GenBank and related public databases. Therefore, we have to consider this isolate as a novel Nocardia species. With the widespread use of typing techniques and sequence-based confirmation of unusual isolates, it is likely that this novel strain will be encountered more than once in the future. An important clinical message of this report is the feasibility of a rather short antibiotic therapy of only 2 months, provided that adequate surgical drainage or repetitive arthrocentesis has been performed. To date, treatments of several months are still recommended for nocardial arthritis due to the risk of recurrence [13] and substantial mortality in the case of disseminated disease [3, 14] . Our review of the literature revealed a median treatment duration of 4 months (with the exception of our treatment protocol), with one report of a 2-year treatment [6] ; these treatments are ubiquitously associated with high cure rates of almost 90% (Table 1) . Unfortunately, we were unable to answer the question of whether the continuous presence of a foreign body-i.e. infection of the joint prosthesis-with implant retention would influence the duration of the concomitant antibiotic treatment. Most nocardial arthritis cases involve native joints or joints with removed osteosynthesis material.
In systemic nocardiosis, the infection usually stems from the lungs of a severely immunocompromised host, and arthritis is typically related to haematogenous seeding [1, 3] . Consequently, prolonged antibiotic treatment durations are probably justified. In contrast, in immunocompetent patients with localised posttraumatic disease in the absence of a foreign body, one probably could combine adequate surgical drainage or arthrocentesis with a much shorter antibiotic course, as illustrated in this case, with 8 weeks of therapy, or in a previous case, with 7 weeks [15] . This combined regimen should reduce the adverse events of a prolonged cotrimoxazole therapy [7] . However, a careful follow-up is warranted when the duration of the antibiotic treatment is reduced, given the paucity of experience with this approach and the novelty of this and future strains. Randomised trials are very likely impossible due to the rarity of the disease, and further reports on the efficacy of relatively short-course antibiotic treatments are clearly warranted.
